Implantation of antibiotic-releasing carriers for treatment of recurrent prosthetic endocarditis.
A 26-year-old man had early recurrence of aortic prosthetic endocarditis with recurrent prosthetic valve dysfunction. Tertiary valve replacement with implantation of antibiotic-releasing carriers for local treatment of aortic root abscesses was performed successfully in this highly lethal condition.
D000328:Adult; D001022:Aortic Valve Insufficiency / Q000601:surgery; D001705:Bioprosthesis / Q000009:adverse effects*; D004343:Drug Implants; D004359:Drug Therapy, Combination; D004697:Endocarditis, Bacterial / Q000188:drug therapy*; D005839:Gentamicins / Q000008:administration & dosage*; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D008297:Male; D011109:Polymethacrylic Acids / Q000008:administration & dosage*; D011183:Postoperative Complications; D011475:Prosthesis Failure; D012086:Reoperation; D013203:Staphylococcal Infections / Q000209:etiology
D004343:Drug Implants; D005839:Gentamicins; D011109:Polymethacrylic Acids